Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.
Publication
, Journal Article
Venook, AP; Blanke, CD; Niedzwiecki, D; Lenz, H-J; Taylor, JR; Hollis, DR; Sutherland, S; Goldberg, RM
Published in: Clin Colorectal Cancer
May 2007
Duke Scholars
Published In
Clin Colorectal Cancer
DOI
ISSN
1533-0028
Publication Date
May 2007
Volume
6
Issue
7
Start / End Page
536 / 538
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasm Staging
- Leucovorin
- Humans
- Fluorouracil
- Colorectal Neoplasms
- Cetuximab
- Biological Products
- Bevacizumab
- Antineoplastic Combined Chemotherapy Protocols
Citation
APA
Chicago
ICMJE
MLA
NLM
Venook, A. P., Blanke, C. D., Niedzwiecki, D., Lenz, H.-J., Taylor, J. R., Hollis, D. R., … Goldberg, R. M. (2007). Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma. Clin Colorectal Cancer, 6(7), 536–538. https://doi.org/10.3816/CCC.2007.n.021
Venook, Alan P., Charles D. Blanke, Donna Niedzwiecki, Heinz-Josef Lenz, John R. Taylor, Donna R. Hollis, Susan Sutherland, and Richard M. Goldberg. “Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.” Clin Colorectal Cancer 6, no. 7 (May 2007): 536–38. https://doi.org/10.3816/CCC.2007.n.021.
Venook AP, Blanke CD, Niedzwiecki D, Lenz H-J, Taylor JR, Hollis DR, et al. Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma. Clin Colorectal Cancer. 2007 May;6(7):536–8.
Venook, Alan P., et al. “Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.” Clin Colorectal Cancer, vol. 6, no. 7, May 2007, pp. 536–38. Pubmed, doi:10.3816/CCC.2007.n.021.
Venook AP, Blanke CD, Niedzwiecki D, Lenz H-J, Taylor JR, Hollis DR, Sutherland S, Goldberg RM. Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma. Clin Colorectal Cancer. 2007 May;6(7):536–538.
Published In
Clin Colorectal Cancer
DOI
ISSN
1533-0028
Publication Date
May 2007
Volume
6
Issue
7
Start / End Page
536 / 538
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasm Staging
- Leucovorin
- Humans
- Fluorouracil
- Colorectal Neoplasms
- Cetuximab
- Biological Products
- Bevacizumab
- Antineoplastic Combined Chemotherapy Protocols